David Encinas is a postdoctoral fellow at the College of Pharmacy of the University of Arizona. His research focuses on lung and nasal powder delivery and the relationship between particle engineering and in vitro/in vivo performance for treating different lung conditions like asthma and pulmonary hypertension; he is also interested in treating fungal infections by drug inhalation delivery. David holds a PhD degree in Nanotechnology from the University of Sonora in Mexico. His primary motivation for working is to find solutions that can improve the lives of patients through innovation
